INFUSYSTEM HOLDINGS, INC Cash and Restricted Cash
INFUSYSTEM HOLDINGS, INC (INFU) had Cash and Restricted Cash of $964.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $964.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.11M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.19M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $955.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $964.00K 10-Q · filed 2026-08-04 |
| 2026-03-31 | $2.11M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.19M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $955.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $720.00K 10-Q · filed 2026-08-04 |
| 2025-03-31 | $1.51M 10-Q · filed 2026-05-08 |
| 2024-12-31 | $527.00K 10-Q · filed 2026-08-04 |
| 2024-09-30 | $380.00K 10-Q · filed 2025-11-04 |
| 2024-06-30 | $146.00K 10-Q · filed 2025-08-05 |
| 2024-03-31 | $822.00K 10-Q · filed 2025-05-08 |
| 2023-12-31 | $231.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $161.00K 10-Q · filed 2024-11-08 |
| 2023-06-30 | $134.00K 10-Q · filed 2024-08-09 |
| 2023-03-31 | $256.00K 10-Q · filed 2024-05-09 |
| 2022-12-31 | $165.00K 10-K · filed 2025-03-11 |
| 2022-09-30 | $363.00K 10-Q · filed 2023-11-09 |
| 2022-06-30 | $311.00K 10-Q · filed 2023-08-09 |
| 2022-03-31 | $405.00K 10-Q · filed 2023-05-09 |
| 2021-12-31 | $186.00K 10-K · filed 2024-04-10 |
| 2021-09-30 | $165.00K 10-Q · filed 2022-11-08 |
| 2021-06-30 | $164.00K 10-Q · filed 2022-08-04 |
| 2021-03-31 | $2.76M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $9.65M 10-K · filed 2024-04-10 |
| 2020-09-30 | $1.94M 10-Q · filed 2021-11-15 |
| 2019-12-31 | $2.65M 10-K · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |